뒤로
HUTCHMED (China) Limited(HMDCF) 가격
HMDCF 주가 차트
HMDCF 수입
HUTCHMED (China) Limited
$3.02
0%
$0
종가: Feb 06, 16:00:00 GMT-5
$3.02
0%
$0
애프터마켓: Feb 06, 20:00:00 GMT-5
최신 수익 결과: Q2 '23
보고됨: 2023-07-31
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
HMDCF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
HUTCHMED (China) Limited HMDCF의 지난 분기 매출 실적은 어땠나요?
HUTCHMED (China) Limited의 매출 추정치는 얼마인가요?
HUTCHMED (China) Limited의 수익 품질 점수는 얼마인가요?
HUTCHMED (China) Limited는 언제 수익을 보고하나요?
HUTCHMED (China) Limited의 예상 수익은 얼마인가요?
HUTCHMED (China) Limited은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$3.02
시가
$3.81
일일 범위
$3.02 - $3.81
52주 범위
$3.02 - $3.81
거래량
468
평균 거래량
180
EPS(TTM)
0.53
배당수익률
--
시가총액
$2.5B
HUTCHMED (CHINA) LIMITED란 무엇인가요?
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. The company employs 1,780 full-time employees The company went IPO on 2006-05-19. The firm operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.